Carmine N. Stengone

Insider Reports History

Location
San Diego, CA
Signature
/s/ Melissa Tosca, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carmine N. Stengone:

Company Role Class Num Shares Value Price $ Report Date Ownership
Contineum Therapeutics, Inc. CEO and President, Director Class A Common Stock 11,612 $197,985 $17.05 04 Apr 2024 Direct
KIORA PHARMACEUTICALS INC Director Common Stock 1,250 $4,600 $3.68 11 Sep 2024 Direct
Contineum Therapeutics, Inc. CEO and President, Director Stock Option (right to buy) 300,000 31 Jan 2025 Direct
KIORA PHARMACEUTICALS INC Director Stock Option (right to buy) 20,000 01 Apr 2025 Direct

Insider Reports Filed by Carmine N. Stengone

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KPRX KIORA PHARMACEUTICALS INC 01 Apr 2025 1 $0 4 Director 02 Apr 2025, 20:11
CTNM Contineum Therapeutics, Inc. 31 Jan 2025 1 $0 4 CEO and President, Director 31 Jan 2025, 16:35
KPRX KIORA PHARMACEUTICALS INC 11 Sep 2024 1 +$4,600 4 Director 12 Sep 2024, 06:32
KPRX KIORA PHARMACEUTICALS INC 01 Jul 2024 1 $0 4 Director 03 Jul 2024, 15:16
CTNM Contineum Therapeutics, Inc. 24 May 2024 1 $0 4 CEO and President, Director 29 May 2024, 17:59
CTNM Contineum Therapeutics, Inc. 04 Apr 2024 0 $0 3 CEO and President, Director 04 Apr 2024, 17:49
KPRX KIORA PHARMACEUTICALS INC 29 Sep 2023 1 $0 4 Director 03 Oct 2023, 16:45
KPRX KIORA PHARMACEUTICALS INC 01 Aug 2023 0 $0 3 Director 10 Aug 2023, 17:23